Protalix BioTherapeutics Inc (PLX)
1.18
+0.03
(+2.61%)
USD |
NYAM |
Apr 22, 16:00
1.17
-0.01
(-0.85%)
After-Hours: 20:00
Protalix BioTherapeutics Cash from Operations (TTM): -1.318M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.318M |
| September 30, 2023 | -7.524M |
| June 30, 2023 | -9.84M |
| March 31, 2023 | -22.17M |
| December 31, 2022 | -25.00M |
| September 30, 2022 | -27.48M |
| June 30, 2022 | -20.15M |
| March 31, 2022 | -6.28M |
| December 31, 2021 | -10.28M |
| September 30, 2021 | -12.75M |
| June 30, 2021 | -14.47M |
| March 31, 2021 | -28.82M |
| December 31, 2020 | -26.11M |
| September 30, 2020 | -22.24M |
| June 30, 2020 | -21.86M |
| March 31, 2020 | -19.20M |
| December 31, 2019 | -19.36M |
| September 30, 2019 | -19.68M |
| June 30, 2019 | -2.811M |
| March 31, 2019 | -5.605M |
| December 31, 2018 | -7.742M |
| September 30, 2018 | 13.85M |
| June 30, 2018 | -10.33M |
| March 31, 2018 | -10.98M |
| December 31, 2017 | -9.994M |
| Date | Value |
|---|---|
| September 30, 2017 | -34.92M |
| June 30, 2017 | -27.83M |
| March 31, 2017 | -30.90M |
| December 31, 2016 | -32.10M |
| September 30, 2016 | -28.62M |
| June 30, 2016 | -33.83M |
| March 31, 2016 | -27.49M |
| December 31, 2015 | -24.28M |
| September 30, 2015 | -25.30M |
| June 30, 2015 | -26.19M |
| March 31, 2015 | -27.36M |
| December 31, 2014 | -29.28M |
| September 30, 2014 | -29.15M |
| June 30, 2014 | -27.82M |
| March 31, 2014 | -29.41M |
| December 31, 2013 | -30.65M |
| September 30, 2013 | -24.09M |
| June 30, 2013 | -23.90M |
| March 31, 2013 | -2.67M |
| December 31, 2012 | 0.635M |
| September 30, 2012 | -7.798M |
| June 30, 2012 | -7.916M |
| March 31, 2012 | -25.86M |
| December 31, 2011 | -23.57M |
| September 30, 2011 | -24.99M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-28.82M
Minimum
Mar 2021
-1.318M
Maximum
Dec 2023
-16.70M
Average
-19.36M
Median
Dec 2019
Cash from Operations (TTM) Benchmarks
| Agenus Inc | -224.20M |
| InfuSystems Holdings Inc | 11.22M |
| Corbus Pharmaceuticals Holdings Inc | -36.10M |
| AIM ImmunoTech Inc | -21.27M |
| Armata Pharmaceuticals Inc | -47.42M |